This module allows you to analyze existing cross correlation between Alnylam Pharmaceuticals and XU100. You can compare the effects of market volatilities on Alnylam Pharmaceuticals and XU100 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of XU100. See also your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and XU100.
|Horizon||30 Days Login to change|
Predicted Return Density
Alnylam Pharmaceuticals Inc vs. XU100
Given the investment horizon of 30 days, Alnylam Pharmaceuticals is expected to generate 1.97 times more return on investment than XU100. However, Alnylam Pharmaceuticals is 1.97 times more volatile than XU100. It trades about 0.14 of its potential returns per unit of risk. XU100 is currently generating about -0.03 per unit of risk. If you would invest 7,180 in Alnylam Pharmaceuticals on August 23, 2019 and sell it today you would earn a total of 1,470 from holding Alnylam Pharmaceuticals or generate 20.47% return on investment over 30 days.
Pair Corralation between Alnylam Pharmaceuticals and XU100
|Time Period||3 Months [change]|
Diversification Opportunities for Alnylam Pharmaceuticals and XU100
Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals Inc and XU100 in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on XU100 and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with XU100. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XU100 has no effect on the direction of Alnylam Pharmaceuticals i.e. Alnylam Pharmaceuticals and XU100 go up and down completely randomly.
See also your portfolio center. Please also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.